Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is 60.30% vs 0.00% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is 10.96% vs 24.24% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is 6.89% vs 29.87% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is 67.31% vs 333.33% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024
Compare Quarterly Results Of Dizal (Jiangsu) Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 22.16% vs 658.57% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 60.30% vs 0.00% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 4.34% vs 33.21% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 10.96% vs 24.24% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 10.21% vs 29.29% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 6.89% vs 29.87% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 2.35% vs 16.44% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 67.31% vs 333.33% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






